Personalis, Inc. Common Stock (PSNL) Stock Price

PSNLStock
$17.25+253.21%52W
Market Cap$1.84B
P/E
PEG Ratio
Div yield
Beta2.32

PSNL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)78.31%
Price vs S&P 500 (4W)40.55%
VGM Score46.95

PSNL Earnings Surprise History

Q2 25-0.23est. -0.24
Q3 25-0.24est. -0.27
Q4 25-0.26est. -0.28
Q1 26-0.29est. -0.28
Q2 26-0.30est. -0.28

PSNL Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.15
4.15
4.15
4.08

Industry Peers — Health Services(30)

About Personalis, Inc. Common Stock

Personalis Inc provides genomic sequencing and analytics solutions that enable the development of personalized cancer vaccines and cancer immunotherapies. The company's portfolio includes ImmunoID NeXT and related diagnostic tests, serving pharmaceutical companies developing next-generation cancer treatments.